BICILLIN C-R 900/300 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bicillin C-r 900/300, and what generic alternatives are available?
Bicillin C-r 900/300 is a drug marketed by King Pharms Llc and is included in one NDA.
The generic ingredient in BICILLIN C-R 900/300 is penicillin g benzathine; penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BICILLIN C-R 900/300?
- What are the global sales for BICILLIN C-R 900/300?
- What is Average Wholesale Price for BICILLIN C-R 900/300?
Summary for BICILLIN C-R 900/300
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Patent Applications: | 21 |
| What excipients (inactive ingredients) are in BICILLIN C-R 900/300? | BICILLIN C-R 900/300 excipients list |
| DailyMed Link: | BICILLIN C-R 900/300 at DailyMed |
Recent Clinical Trials for BICILLIN C-R 900/300
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Tennessee | Phase 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
Pharmacology for BICILLIN C-R 900/300
| Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for BICILLIN C-R 900/300
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms Llc | BICILLIN C-R 900/300 | penicillin g benzathine; penicillin g procaine | INJECTABLE;INJECTION | 050138-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
